DRAK2, active

active DRAK2. N-terminal 6His-tagged, recombinant, full length, human DRAK2.

Catalog #: 16-003

$399.00$2,989.00


Inquire
Biological Information
Background Information:
DRAK2, also known as Serine/Threonine Kinase 17b, enables ATP binding activity and protein serine/threonine kinase activity. It involves in intracellular signal transduction and positive regulation of fibroblast apoptotic process. [provided by Alliance of Genome Resources, Apr 2022]
Target Class:
Kinase
Accession Number:
NM_004226.4
Target Name:
DRAK2
Target Aliases:
STK17B, Serine/Threonine Kinase 17b, Death-Associated Protein Kinase-Related 2, Serine/Threonine Kinase 17b (Apoptosis-Inducing)
Target Species:
Human
Usage
Product Type:
Enzymes
Application:
Drug Discovery & Development
Storage Conditions:
1 year at -70°C
Usage Disclaimer:
These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Datasheets

16-003x Datasheet

View Document